PXI Auto Components
301560
Shenzhen Crastal Technology
300824
Shenzhen Zesum Technology
301486
4
Henan Shijia Photons Technology
688313
5
Hanjia Design Group
300746
CN Stock MarketDetailed Quotes
301108 Tongling Jieya Biologic Technology
- 27.16
- -0.33-1.20%
Trading Apr 25 13:56 CST
2.18BMarket Cap140.00P/E (TTM)
28.46High26.94Low24.42KlotVolume27.55Open27.49Pre Close67.67MTurnover7.09%Turnover Ratio112.23P/E (Static)80.40MShares32.2352wk High1.19P/B935.01MFloat Cap20.8152wk Low32.99Limit Up34.43MShs Float95.97Historical High21.99Limit Down5.53%Amplitude20.81Historical Low0.36Dividend TTM27.71Avg Price11.65KlotAsk1.33%Div YieldTTM100Lot Size11.21KlotBid
Tongling Jieya Biologic Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -4.62%123.65M | -12.07%547.45M | -8.79%407.97M | 1.99%285.07M | 1.43%129.64M | -6.60%622.59M | -14.91%447.27M | -22.26%279.52M | -29.24%127.8M | -32.29%666.56M |
| Operating revenue | -4.62%123.65M | -12.07%547.45M | -8.79%407.97M | 1.99%285.07M | 1.43%129.64M | -6.60%622.59M | -14.91%447.27M | -22.26%279.52M | -29.24%127.8M | -32.29%666.56M |
| Other operating revenue | ---- | -73.41%8.03M | ---- | -80.55%3.57M | ---- | 65.43%30.2M | ---- | 18.54%18.36M | ---- | 28.38%18.25M |
| Total operating cost | -4.84%118.17M | -0.80%509.4M | 6.06%385.58M | 20.49%264.89M | 32.12%124.19M | 0.21%513.52M | -2.48%363.56M | -13.78%219.84M | -27.22%93.99M | -30.88%512.42M |
| Operating cost | -5.09%99.23M | 0.42%439.98M | 7.38%328.67M | 22.01%228.34M | 31.10%104.56M | -4.09%438.15M | -12.80%306.09M | -22.87%187.16M | -33.97%79.75M | -30.91%456.83M |
| Operating tax surcharges | 11.52%1.42M | -36.13%4.19M | -25.23%3.02M | -6.24%2.35M | 13.67%1.28M | 35.21%6.57M | 20.64%4.04M | 79.79%2.51M | 94.22%1.12M | -31.86%4.86M |
| Operating expense | -48.70%1.31M | -2.01%9.47M | -8.78%7.58M | 33.96%4.98M | 69.06%2.55M | 34.86%9.66M | 107.14%8.31M | 60.06%3.71M | 66.71%1.51M | 2.99%7.16M |
| Administration expense | -1.27%11.99M | -7.12%45.1M | 3.01%37.78M | 14.33%25.53M | 10.82%12.14M | 38.08%48.56M | 59.24%36.67M | 72.27%22.33M | 74.95%10.96M | 30.31%35.17M |
| Financial expense | 25.89%-1.2M | 17.75%-9.82M | 32.12%-6.35M | 12.03%-6.28M | 63.53%-1.62M | 29.28%-11.94M | 66.22%-9.36M | 59.76%-7.14M | 18.35%-4.44M | -730.32%-16.89M |
| -Interest expense (Financial expense) | -55.61%92.23K | -23.90%769.02K | -17.02%536.3K | -88.71%411.26K | -22.31%207.75K | -45.80%1.01M | -54.21%646.28K | 283.54%3.64M | -44.19%267.39K | 14.89%1.86M |
| -Interest Income (Financial expense) | 31.58%-1.58M | 38.05%-7.35M | 17.44%-6.67M | 37.24%-5.7M | 26.92%-2.31M | 6.45%-11.86M | 53.92%-8.08M | 21.78%-9.08M | 43.07%-3.16M | -109.50%-12.68M |
| Research and development | 2.67%5.42M | -9.07%20.48M | -16.44%14.88M | -11.57%9.97M | 3.64%5.28M | -10.96%22.52M | -6.72%17.81M | -15.83%11.27M | -15.81%5.09M | -30.48%25.29M |
| Credit Impairment Loss | -126.02%-427.23K | -810.54%-8.06M | -27.36%690.79K | -12.75%467.03K | -41.70%1.64M | 239.33%1.14M | 158.17%951.02K | 127.40%535.28K | 382.24%2.82M | -17.42%-814.6K |
| Asset Impairment Loss | 248.84%680.82K | -135.21%-28.17M | -233.20%-1.73M | -283.98%-1.38M | 290.86%195.17K | -158.37%-11.98M | 92.73%-517.79K | 89.55%-359.54K | 88.35%-102.26K | -155.34%-4.64M |
| Other net revenue | -52.51%4.34M | -152.84%-13.62M | -26.06%16.5M | -34.73%9.52M | 1.35%9.13M | 46.56%25.78M | 855.56%22.31M | 2,571.46%14.59M | 167.51%9.01M | 161.45%17.59M |
| Fair value change income | -60.52%985.56K | 17.12%10.61M | 53.76%7.22M | 111.05%4.2M | 970.18%2.5M | 795.57%9.06M | 213.11%4.7M | 188.68%1.99M | -82.90%233.27K | -15.57%1.01M |
| Invest income | -55.30%1.7M | -57.79%7.82M | -42.79%7.19M | -53.55%4.38M | -15.59%3.8M | 55.44%18.52M | 563.12%12.57M | 1,276.78%9.43M | --4.5M | --11.92M |
| -Including: Investment income associates | -38.94%-1.29M | -1,281.28%-11.19M | ---7.98M | ---5.49M | ---927.09K | ---810.05K | ---- | ---- | ---- | ---- |
| Asset deal income | 2,652.73%167.7K | -109.34%-29.85K | 70.45%-29.85K | -77.37%-29.85K | -52.71%6.09K | -72.18%319.55K | -312.96%-101.01K | -124.44%-16.83K | --12.88K | 295.26%1.15M |
| Other revenue | 23.90%1.23M | -51.63%4.22M | -33.21%3.15M | -37.30%1.89M | -35.86%994.39K | -2.74%8.72M | -41.15%4.72M | -52.19%3.01M | -32.53%1.55M | 15.69%8.96M |
| Operating profit | -32.68%9.82M | -81.88%24.43M | -63.32%38.89M | -60.00%29.71M | -65.94%14.58M | -21.48%134.85M | -29.26%106.02M | -28.58%74.26M | -21.91%42.82M | -31.27%171.73M |
| Add:Non operating Income | -99.38%7.3K | 277.76%1.58M | 246.56%1.36M | 674.90%1.36M | 13,888.41%1.17M | -43.16%417.93K | -37.51%391.83K | -71.30%175.08K | -95.83%8.38K | -70.81%735.25K |
| Less:Non operating expense | -82.64%107.04K | 230.96%860.33K | 234.06%731.6K | 528.04%673.78K | 66,115.10%616.75K | -97.48%259.95K | -90.45%219K | -95.09%107.28K | -99.83%931.44 | 1,931.73%10.3M |
| Total profit | -35.81%9.72M | -81.37%25.15M | -62.79%39.51M | -59.12%30.39M | -64.65%15.14M | -16.75%135.01M | -28.35%106.2M | -27.41%74.33M | -21.38%42.83M | -35.61%162.16M |
| Less:Income tax cost | -126.13%-331.26K | -70.82%5.97M | -62.65%4.94M | -58.33%3.89M | -77.22%1.27M | -3.46%20.46M | -31.37%13.24M | -29.49%9.34M | -20.83%5.56M | -33.35%21.2M |
| Net profit | -27.55%10.05M | -83.26%19.17M | -62.81%34.57M | -59.23%26.5M | -62.77%13.87M | -18.75%114.54M | -27.90%92.96M | -27.10%64.99M | -21.47%37.26M | -35.94%140.97M |
| Net profit from continuing operation | -27.55%10.05M | -83.26%19.17M | -62.81%34.57M | -59.23%26.5M | -62.77%13.87M | -18.75%114.54M | -27.90%92.96M | -27.10%64.99M | -21.47%37.26M | -35.94%140.97M |
| Less:Minority Profit | 56.36%-12.8K | 55.71%-290.52K | 81.26%-115.1K | 16.71%-91.06K | -280.73%-29.33K | ---655.9K | ---614.36K | ---109.33K | ---7.7K | ---- |
| Net profit of parent company owners | -27.61%10.06M | -83.10%19.46M | -62.94%34.68M | -59.16%26.59M | -62.70%13.9M | -18.28%115.2M | -27.42%93.58M | -26.98%65.1M | -21.45%37.27M | -35.94%140.97M |
| Earning per share | ||||||||||
| Basic earning per share | -23.53%0.13 | -83.10%0.24 | -62.61%0.43 | -58.75%0.33 | -63.04%0.17 | -18.39%1.42 | -27.67%1.15 | -27.27%0.8 | -20.69%0.46 | -50.57%1.74 |
| Diluted earning per share | -23.53%0.13 | -83.10%0.24 | -62.61%0.43 | -58.75%0.33 | -63.04%0.17 | -18.39%1.42 | -27.67%1.15 | -27.27%0.8 | -20.69%0.46 | -50.57%1.74 |
| Other composite income | ||||||||||
| Total composite income | -27.55%10.05M | -83.26%19.17M | -62.81%34.57M | -59.23%26.5M | -62.77%13.87M | -18.75%114.54M | -27.90%92.96M | -27.10%64.99M | -21.47%37.26M | -35.94%140.97M |
| Total composite income of parent company owners | -27.61%10.06M | -83.10%19.46M | -62.94%34.68M | -59.16%26.59M | -62.70%13.9M | -18.28%115.2M | -27.42%93.58M | -26.98%65.1M | -21.45%37.27M | -35.94%140.97M |
| Total composite income of minority owners | 56.36%-12.8K | 55.71%-290.52K | 81.26%-115.1K | 16.71%-91.06K | -280.73%-29.33K | ---655.9K | ---614.36K | ---109.33K | ---7.7K | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.